By Mariam Sunny Jan 26 (Reuters) - Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy slowed disease ...

A commercial partnership between Topcon Healthcare and RemoniHealth is integrating the latter’s home-based ocular disease ...

“Weight-loss methods, whether with pharmacotherapy or surgery, have to be mindful to avoid inducing these complications,” ...

A string of clinical and regulatory milestones in the December quarter highlighted growing momentum for ASX health stocks ...

Transthyretin amyloidosis (ATTR) is a rare, progressive and highly aggressive degenerative disease. It is caused by the ...

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...

Fast-RSOM skin scan identifies early cardiovascular risk by imaging tiny blood vessels and functional changes before symptoms ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent chronic liver condition globally, with its management spanning ...

Jan 26 (Reuters) - Sarepta Therapeutics' gene therapy for a muscle‑wasting disorder slowed disease progression and showed sustained benefit in patients' ability to control and coordinate movement ...

Apple Watch now supports glucose monitoring via CGMs like Dexcom G7, while Apple continues long-term work on non-invasive blood sugar tracking.

A case report highlights pulmonary siderosis in a welder with progressive dyspnea and recurrent infections, underscoring occupational history, possible systemic iron overload, and the need to monitor ...